Lucknow, India

Arvind Kumar Srivastava

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.5

ph-index = 1


Location History:

  • Lucknow-226001, IN (2010)
  • Lucknow, IN (2003 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Arvind Kumar Srivastava: Innovator in Metabolic Disorder Treatments

Introduction

Arvind Kumar Srivastava is a prominent inventor based in Lucknow, India. He has made significant contributions to the field of therapeutic agents aimed at treating metabolic disorders. With a total of 7 patents to his name, his work focuses on innovative solutions for diabetes and related conditions.

Latest Patents

Among his latest patents, Srivastava has developed novel substituted 4,5-dihydro-2H-benzo[e]indazole-9-carboxylates. These compounds are designed to serve as therapeutic agents for the treatment and prevention of metabolic disorders. His research emphasizes the preparation of these compounds and their application in diabetes treatment. Additionally, he has created a pharmaceutical composition that utilizes a bioactive fraction effective for treating diabetes and dyslipidemia. This composition can be administered as an antidiabetic and antidyslipidemic agent. Furthermore, he has worked on isomeric xyloccensins and their pharmaceutical applications in treating dyslipidemia.

Career Highlights

Arvind Kumar Srivastava has been associated with the Council of Scientific & Industrial Research, where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding and treatment of metabolic disorders.

Collaborations

Throughout his career, Srivastava has collaborated with notable colleagues, including Deepak Raina and Anil Kumar Rastogi. These partnerships have enhanced his research and innovation efforts.

Conclusion

Arvind Kumar Srivastava stands out as a key figure in the development of therapeutic solutions for metabolic disorders. His innovative patents and collaborative efforts continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…